These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 5296799)

  • 1. [The evaluation of a new hypotensive agent Ro 5-3307 (Declinax)].
    Serra AN; Gonzaga L; Vieira RR; Bulcão J
    Hospital (Rio J); 1966 Jul; 70(1):185-90. PubMed ID: 5296799
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical trial of a new sympathoplegic hypotensive agent].
    Lebacq E; Tirzmalis A; Gossart J; Gilon L; Stenier P
    Sem Hop; 1969 Dec; 45(50):3197-202. PubMed ID: 4312510
    [No Abstract]   [Full Text] [Related]  

  • 3. Declinax--a new hypotensive agent.
    Drug Ther Bull; 1967 May; 5(11):44. PubMed ID: 6046919
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of arterial hypertension. Preliminary clinical observations using RO 5-3307 (Declinax)].
    Faria E; Leite PP; de Loyola Buquera LA; Selmi AE; do Amarilho IP; de Freitas AP
    Hospital (Rio J); 1967 Feb; 71(2):476-9. PubMed ID: 5302399
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical evaluation of Declinax in Nigerian hypertensives.
    Cole TO; Adadevoh BK
    Br J Clin Pract; 1970 Jun; 24(6):245-9. PubMed ID: 5456743
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical trials of a new hypotensive agent, R.O. 5,3307].
    Jouve A; Medvedowsky JL; Poggi L
    Mars Med; 1966; 103(10):745-50. PubMed ID: 5959766
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of arterial hypertension with the prolonged use of Ro 5-3 307].
    Faerchtein I; Roque AF; Cwajg F; Kastansky I; Kac LB
    Rev Bras Med; 1966 Nov; 23(11):790-2. PubMed ID: 5999143
    [No Abstract]   [Full Text] [Related]  

  • 8. [Work capacity evaluation in hypertension and its dynamics during long-term hypotensive therapy].
    Volkov VS; Tsikulin AE
    Ter Arkh; 1980; 52(10):61-3. PubMed ID: 7444785
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical trial of a new hypotensive agent, L.D. 3612 H].
    Delahaye JP; Delaye J
    J Med Lyon; 1966 Dec; 47(111):1853-4. PubMed ID: 5990287
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental and clinical study on a new hypotensive agent: Ismelin (S. U. 5864)].
    DE LA BARREDA P; ORTEGA R; RAPADO A
    Rev Clin Esp; 1960 Sep; 78():254-7. PubMed ID: 13720571
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of new hypotensive agent esbatal for treatment of the patients with hypertension].
    Borisenko AP
    Vrach Delo; 1967 Feb; 2():138-40. PubMed ID: 5617007
    [No Abstract]   [Full Text] [Related]  

  • 12. [Usefulness of nifedipine in the complex hypotensive treatment].
    Sznajderman M; Cybulska I; Makowiecka-Cieśla M
    Pol Tyg Lek; 1983 Dec 19-26; 38(51-52):1659-62. PubMed ID: 6382208
    [No Abstract]   [Full Text] [Related]  

  • 13. [Double-blind assay of a new hypotensive agent of central action, guanfacine, compared with alpha-methyldopa].
    Jiménez Casado M; Canto J; Yapur H; Oller JM
    Rev Clin Esp; 1984 Jul 15-31; 174(1-2):41-4. PubMed ID: 6393236
    [No Abstract]   [Full Text] [Related]  

  • 14. A clinical evaluation of debrisoquine sulphate.
    Somers K; Sood NK; Brenton DP
    Br J Clin Pract; 1968 Sep; 22(9):387-91. PubMed ID: 5672547
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic trials with the new antihypertensive agent Tadip].
    Stein G
    Med Klin; 1968 Sep; 63(37):1466-8. PubMed ID: 5730203
    [No Abstract]   [Full Text] [Related]  

  • 16. [Longterm treatment with a new antihypertensive agent].
    Wolkerstorfer H
    Wien Med Wochenschr; 1969 Jun; 119(25):502-4. PubMed ID: 5802413
    [No Abstract]   [Full Text] [Related]  

  • 17. [Trial of a hypotensive derivative of tetrahydroisoquinoline (RO 5-33-07)].
    Horeau J; Bureau L; Guenel J
    Clinique (Paris); 1966 Jan; 60(615):63-6. PubMed ID: 5907599
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical experiences with a new combination antihypertensive agent (DCR 515)].
    Sterz H; Himmel G; Haas H; Samee HJ
    Wien Klin Wochenschr; 1969 Jan; 81(5):86-90. PubMed ID: 5773905
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hypotensive action of DL-(methylene-3-4) phenyl 2 hydroxy-2-acetamidine hydrocloride (LL-1418)].
    Duteil J; Sautai M; Pessonnier A; Gombert R; Assous E
    Therapie; 1969; 24(4):723-33. PubMed ID: 5822010
    [No Abstract]   [Full Text] [Related]  

  • 20. [First clinical experiences with a new hypotensive substance in severe forms of hypertension].
    Bergström J; Bergquist-Poppen M; Bucht H
    Arzneimittelforschung; 1966 Dec; 16(12):1606-10. PubMed ID: 6014792
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.